Evidence map›Paper›PMID 34159865›Full record

ArticleTechnology in cancer research & treatment

Prognostic Value of Immune-Related lncRNA SBF2-AS1 in Diffuse Lower-Grade Glioma.

Qiang Zhang, Xiao-Jun Liu, Yang Li, Xiao-Wei Ying, Lu Chen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Qiang ZhangDepartment of Clinical laboratory, The People's Hospital of Lishui, Lishui, Zhejiang, China.
Xiao-Jun LiuExternal Liaison Office, The Central Hospital of Lishui City, Lishui, Zhejiang, China.
Yang LiThe Emergency Department, The Central Hospital of Lishui City, Lishui, Zhejiang, China.
Xiao-Wei YingDepartment of Hepatopancreatobiliary Surgery, The People's Hospital of Lishui, Lishui, Zhejiang, China.ORCID 0000-0003-1308-340X
Lu ChenDepartment of Hepatopancreatobiliary Surgery, The People's Hospital of Lishui, Lishui, Zhejiang, China.
Lishui City People's Hospital · CNLishui Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

LncRNA SET-binding factor 2 (SBF2) antisense RNA1 (SBF2-AS1) has been proven to play an oncogenic role in various types of tumors, but the prognostic role of SBF2-AS1 in tumors, especially in diffuse lower-grade glioma (LGG), is still unclear. Here, we aimed to investigate the prognostic value of SBF2-AS1 in LGG. The LGG expression profiles from The Cancer Genome Atlas (TCGA,

Indexed as

AdultBiomarkers, TumorCentral Nervous System NeoplasmsDatabases, GeneticFemaleGene ExpressionGliomaHumansImmunityIsocitrate DehydrogenaseKaplan-Meier EstimateMaleMutationNeoplasm GradingPrognosisProportional Hazards ModelsBiomarkers, TumorIsocitrate Dehydrogenaselong non-coding RNA SBF2-AS1, humanRNA, Long Noncodingdiffuse lower-grade gliomasimmunityprognostic biomarkerSBF2-AS1survival

Identifiers

PMID34159865
PMCPMC8226362
OpenAlexW3174833117

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.